Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00086099
Status:
COMPLETED
Last Update Posted:
2009-01-29
First Post:
2004-06-23
Brief Title:
Study Evaluating the Addition of Amifostine Ethyol to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia
Sponsor:
MedImmune LLC
Organization:
MedImmune LLC
Organization Data
Organization:
MedImmune LLC
Class:
INDUSTRY
Study ID:
MI-CP103
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
MedImmune LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Dirk J Reitsma MD
Old Organization:
MedImmune LLC